Cytokinetics reported $-160.3M in EBITDA for its fiscal quarter ending in June of 2026.





Ebitda Change Date
Acadia Pharmaceuticals USD 40.99M 42.62M Jun/2026
Amgen USD 5.8B 1.25B Sep/2026
Arca Biopharma USD -25.07M 5.23M Mar/2025
Bayer EUR 1.62B 529M Sep/2026
Biogen USD 450.8M 198.9M Jun/2026
Brainstorm Cell Therapeutics USD -3.04M 99K Mar/2025
Bristol-Myers Squibb USD 3.48B 1.6B Sep/2026
Capricor Therapeutics USD -27.23M 2.66M Jun/2025
Cytokinetics USD -160.3M 9.02M Jun/2026
Eisai JPY 25.94B 8.21B Sep/2026
Eli Lilly USD 9.46B 3.54B Sep/2026
Exelixis USD 275.36M 19.96M Sep/2026
Geron USD -9.2M 13.03M Jun/2026
Halozyme Therapeutics USD 336.16M 7.34M Sep/2026
Ionis Pharmaceuticals USD -95.22M 9.99M Sep/2026
Ligand Pharmaceuticals USD 74.27M 88.56M Jun/2026
Merck USD 1.42B 2.97B Jun/2026
Novartis USD 8.62B 2.14B Sep/2026
Pfizer USD 6.36B 350M Sep/2026
Regeneron Pharmaceuticals USD 1.66B 695.2M Jun/2026
Roche Holding CHF 13.43B 744M Jun/2026
Sanofi EUR 5.79B 2.1B Sep/2026